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              Increased Expiratory Computed Tomography Density Reveals
Possible Abnormalities in Radiologically Preserved
Lung Parenchyma in Idiopathic Pulmonary FibrosisdValentina Petroulia, MD,* Manuela Funke, MD,† Pascal Zumstein,† Sabina Berezowska, MD,‡
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Johannes Heverhagen, MD,* and Alexander Poellinger, MD*
can be sufficient for diagnosis if a definite UIP pattern is diagnose
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n-Objectives: Idiopathic pulmonary fibrosis (IPF) is a progressive lethal chron
lung disease with unclear pathogenesis. Radiological hallmark is the pattern
usual interstitial pneumonia accentuated in peripheral and basal areas with othe
wise preserved lung structure. One hypothesis is that alveolar collapse and co
sequent induration lead to fibrotic transformation of lung tissue. The aim of t
study was to investigate normal-appearing tissue during expiration for signs
collapsibility and differences from other diseases or controls.
Materials andMethods:We retrospectively assessed a total of 43 patients (15 IPF
13 chronic obstructive pulmonary diseases, and 15 controls) with nonenhanc
computed tomography (CT) in inspiration and expiration, performed for routi
clinical workup. Densitometry of visually unaffected lung tissue was conduct
in all lung lobes with a region of interest of 15-mm in diameter on soft tissue ke
nel reconstruction (slice thickness, 1 mm) during inspiration and expiration.
Results:One-factor analysis of variance analysis yielded significant difference
attenuation changes between inspiration and expiration of unaffected lung pare
chyma among all subject groups in all lung lobes. For IPF patients, the highe
differences in densities were observed in the lower lobes, which is the predom
nantly affected site of usual interstitial pneumonia. In the chronic obstructive pu
monary disease group, the density remained rather equal in the entire lung.
Conclusions:High CTattenuation changes between inspiration and expiration
IPF patients might suggest altered lung parenchyma in normal-appearing tiss
on CT. Density changes during the respiratory cycle might be explained by alv
olar collapse of radiologically unaffected lung tissue possibly preceding fibr
sis. These results support the concept of alveolar collapse preceding lun
fibrosis in IPF.
Key Words: idiopathic pulmonary fibrosis, COPD, ACOS, emphysema,
collapse induration, CT density, inspiratory density, expiratory density,
alveolar collapse
(Invest Radiol 2018;00: 00–00)
I diopathic pulmonary fibrosis (IPF) is a devastating lung disease, chaacterized by a progressive fibrosis of the lung parenchyma. Radiolo
ical hallmark of IPF is the so-called usual interstitial pneumonia (UI
pattern, which is characterized by reticular opacities, traction bronchie
tasis, and commonly honeycombing, while ground glass is less pr
dominant.1 Usual interstitial pneumonia on high-resolution compute
tomography (CT) is essential for IPF diagnosis, and imaging itseReceived for publication April 30, 2017; and accepted for publication, after revision,
July 10, 2017.
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                              This paper can be cited using the date of access and theand there is no clinical suspicion of other diseases associated with a
UIP pattern.1 Further analysis of thoracic CT data of IPF patients usin
densitometric and histogram-based analyses has been proven to corr
late with pulmonary function tests and was associated with transplan
free survival.2
The pathogenesis of IPF remains undetermined. Current hypot
eses blame chronic lung injury and abnormalwound healing3 for the e
cessive scarring observed in IPF lungs. In addition, impaired functio
with alveolar collapse might lead to collapse induration4,5 and thus de
sified lung tissue.
In contrast to lung fibrosis, chronic obstructive pulmonary di
ease (COPD) is defined by chronic airflow limitation caused by
mixture of small airways disease (eg, obstructive bronchiolitis) and p
renchymal destruction (emphysema).6 It is commonly induced by t
bacco smoking and prevalent in this population.7 If the patient has a
overlap syndrome with an asthmatic component, the term ACO
(asthma and chronic obstructive overlap syndrome) is used.8 Radiolo
ical characteristics of COPD are thickened bronchial walls, where
emphysema is characterized by rarefication of lung parenchyma.9,
Air trapping represents another hallmark in the COPD spectrum.
Having observed that normal-appearing parenchyma in the lun
of IPF patients presents very dense in expiratory CT scans, we intende
to investigate this phenomenonmore in detail. The purpose of this stud
was to research the effects of inspiration and expiration on CT attenu
tion of the lung in IPF and COPD (including emphysema and ACO
subtypes) compared with patients with radiologically healthy-appearin
lungs and no known lung disease.s,
al
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dMATERIALS AND METHODS
The study was approved by the Ethics Committee of Be
(BASEC No. 2016–01632).
Computed tomography chest scans of 15 patients with IPF, dia
nosed according to the current ATS/ERS guidelines,1 13 patients wi
COPD, with or without radiological emphysema or ACOS (summ
rized as COPD for simplification), which were diagnosed in the pre
ence of FEV1/FVC < 70% and/or with associated features of COP
and asthma (ACOS) according to current GOLD guidelines,11,12 an
15 controls, who received CT scan for various medical reasons (eg, u
clear dyspnea) without radiological lung parenchymal abnormalitie
were retrospectively analyzed. All patients underwent CT scans for medic
indications at our institution between February 01, 2015, and October 3
2016, and were selected in a consecutive order.
Chest CT Examination and Acquisition
Non–contrast-enhanced CT scans were performed for all subjec
using a 128-detector row CT scanner (Siemens SOMATOMDefinitio
FLASH; Siemens Medical Solutions, Erlangen, Germany) or a 6
detector row CT scanner Philips Brilliance 64 (Philips Medical System
Best, the Netherlands) as part of routine clinical workup. Computewww.investigativeradiology.com 1
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              tomography scans were performed during end-inspiratory and en
expiratory breath-hold. Images were acquired in supine position fro
apex of the lung to the costodiaphragmatic recess. No intravenous co
trast agent was administered.
A tube voltage of 120 kVp or 100 kVp was applied, which w
kept constant between inspiratory and expiratory scans for each patien
A standard dose protocol was chosen for inspiratory scans and a low
dose protocol for the expiratory scans, both applying automated exp
sure control with tube current modulation (CARE Dose4D Siemen
Health Care; DoseRight, Philips Healthcare). Consequently, tube cu
rent modulation resulted in a mean value of 105.3 mA (SD, 44.7) in i
spiration and 55.7 mA (SD, 32.3) in expiration. Scans that covere
the entire thorax were acquired with spiral acquisition and a slice thic
ness of 1 mm. The pixel matrix was 512  512, collimation w
128 0.6 mm, pitch was 0.6, and rotation timewas 0.28 second. Sieme
Sinogram-Affirmed Iterative Reconstruction (SAFIRE, strength 3) secon
generation iterative reconstruction (kernel I31f ) was used for imag
reconstruction on scans obtained using a Siemens SOMATOMDefin
tion FLASHMDCT. For the scans acquired with Philips Brilliance 6
iterative reconstruction with iDose (strength 4, kernel Standard B
was applied.
Lobe-Based CT Densitometry
Lobe-based CT densitometry was performed for all lung lobes
both inspiration and expiration by 2 readers with 4 and 17 years of e
perience in reading CTs of the lung. A region of interest (ROI) with
diameter of 15 mm was drawn to measure the attenuation values
unaffected-appearing lung parenchyma in axial images of 1 mm thic
ness in the lung window (window level, −500 Hounsfield units [HU
window width, 1500 HU).
In IPF and COPD subjects, the ROI was positioned as far
possible from the radiologically affected lung tissue, that is, into are
without features of fibrosis or emphysema. Vessels were exclude
whenever possible.
Statistical Analysis
Statistical analysis was performed with IBM SPSS Statistic
version 21 (IBM, Armonk, NY). Normal distribution of data was teste
using the Shapiro-Wilk test. One-factor analysis of variance (ANOVA
analysis was used to compare absolute attenuation values and attenu
tion changes between inspiration and expiration in all lung lobes b
tween subject groups. A 2-tailed paired student t test was applied f
comparing attenuation changes between the upper and lower lobe in di
ferent subject groups. The Mann-WhitneyU test was performed for a
solute HU values between IPF patients and controls as well as betweeTABLE 1. Pulmonary Function Tests of Controls, COPD, and IPF Patien
Other Numbers Are Reported in Parentheses)
Parameter Control
FVC (l) 2.97 ± 1.05
FVC (%) 88.75 ± 26.15
TLC (l) 5.19 ± 1.8 (n = 9)
TLC (%) 92 ± 18.05 (n = 9)
FEV 1 (l) 2.33 ± 0.72
FEV 1 (%) 85.92 ± 25.25
corr DLCO 5.76 ± 2.06 (n = 10)
DLCOc (%) 71.89 ± 21.27 (n = 10)
Data present mean ± SD.
COPD indicates chronic obstructive pulmonary disease; IPF, idiopathic pulmonary
volume in 1 second; DLCO, diffusion capacity of the lung for carbon monoxide.
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                              This paper can be cited using the date of access and theIPF patients and COPD patients. Differences were considered statis
cally significant with a P value of less than 0.05.
Interobserver variability was tested with the intraclass correlatio
coefficient (ICC), an index of interrater reliability of quantitative dat
For the generation of 3-dimensional receiver operating characterist
(ROC) surfaces, we used R (v. 3.4.0), boot (v.1.3-19), and plotly (v.4.7.
with adapted scripts applying the methods of Nakas and Yiannoutsos
to generate and illustrate the empirical 3-dimensional ROC surfac
and their respective volume under the ROC surface (VUS). For th
95% confidence intervals, we used the bias-corrected and accelerate
method as proposed by Efron,14 based on R = 5000 bootstrap replicate
RESULTS
Patients' Characteristics
The study included a total of 43 subjects, 15 patients with dia
nosed IPF (mean age, 64.6 years; range, 53–83 years), 13 patients wi
a diagnosis of COPD of various degree including emphysematous su
types and ACOS (mean age, 61.9 years; range, 44–79 years), and 15 su
jects with no radiological features of an interstitial lung disease (ILD)
emphysema (mean age, 50.6 years; range, 24–78 years). Thirty-two ma
and 13 female patients were included. Eight of the IPF patients exhi
ited UIP pattern and 7 patients possible UIP pattern.
Pulmonary function tests were available for 12 patients of th
control group, for 12 patients of the COPD group, and for all IP
patients (Table 1).
Absolute Attenuation Values
Hounsfield units were measured in all lobes in inspiration an
expiration (Table 2). Attenuation values in inspiration of IPF patien
are in the range of controls. In expiration, there is a marked increa
in attenuation, especially in the lower lobes. Figure 1 illustrates the a
tenuation changes in a subject with IPF. To compare absolute HU valu
between groups, a Mann-WhitneyU test was performed. In inspiratio
there was no difference in the attenuation between IPF patients and co
trols (P= 0.174). On the contrary, in expiration, significant differences we
observed (P < 0.001). A comparison between HU values of COPD p
tients and IPF patients yielded significant differences for inspiratio
and expiration (P < 0.001) (Fig. 2).
Comparison of Attenuation Changes Between Subjec
Groups in Inspiration and Expiration
Changes in the HU for all lung lobes between inspiration and e
piration were highest in the IPF group, followed by controls, and lowe
in the COPD group (Table 3). Representative images of 3 individuats as Available (Control n = 12, Emphysema/COPDn = 12, and IPF n = 15,
COPD IPF
3.93 ± 1.11 2.59 ± 0.8
96 ± 22.55 60.33 ± 15.95
7.35 ± 1.09 (n = 9) 4.38 ± 1.16 (n = 13)
113.33 ± 16.16 (n = 9) 60.31 ± 13.21 (n = 13)
2.23 ± 1.08 2.18 ± 0.7
69.33 ± 30.02 66.6 ± 19.12
5.65 ± 1.93 (n = 11) 4.24 ± 1.28
62.91 ± 17.33 (n = 11) 46.4 ± 12.93
fibrosis; FVC, forced vital capacity; TLC, total lung capacity; FEV 1, forced expiratory
© 2017 Wolters Kluwer Health, Inc. All rights reserved.
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TABLE 2. Absolute Attenuation in HU in the Upper Lobes, Middle Lobe/Lingula, and Lower Lobes With Standard Deviation for the Different
Groups in Inspiration and Expiration
Controls COPD IPF
Inspiration, HU Expiration, HU Inspiration, HU Expiration, HU Inspiration, HU Expiration, HU
Upper lobe R1 −874.5 ± 28.4 −800.7 ± 42.2 −899.5 ± 19.9 −838.9 ± 50.2 −852.9 ± 37.5 −712.0 ± 72.7
R2 −880 ± 29.6 −807 ± 42.8 −899.9 ± 22.8 −846.3 ± 46.9 −852.6 ± 41.3 −711.1 ± 87.7
Middle lobe/lingula R1 −881.6 ± 30.0 −809.7 ± 44.1 −901.4 ± 31.8 −839.6 ± 56.6 −858.2 ± 37.9 −718.0 ± 79.1
R2 −881.8 ± 32.9 −815.6 ± 40.6 −900.2 ± 33.5 −853.7 ± 52.4 −848.2 ± 40.0 −715.7 ± 67.3
Lower lobe R1 −858.3 ± 46.4 −733.2 ± 81.2 −891.1 ± 41.3 −819.7 ± 73.3 −837.5 ± 53.6 −605.6 ± 115.4
R2 −854 ± 45.0 −720.9 ± 84.6 −881.0 ± 45.7 −819.6 ± 70.4 −816.4 ± 61.7 −555.1 ± 121.5
HU indicates Hounsfield units; COPD, chronic obstructive pulmonary disease; R1, reader 1; R2, reader 2.
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              are presented in Figure 3. A 1-factor ANOVA analysis yielded signif
cant differences of the density changes between the groups for eac
lung lobe (for all lobes: P < 0.001) (Fig. 4). The highest differenc
in the attenuation changes between inspiration and expiration were o
served in the lower lobes of IPF patients, which represent the lung are
predominantly affected by UIP.
Comparison of Upper Versus Lower Lobes
Attenuation Changes
A 2-tailed paired t test was used to compare attenuation chang
between upper and lower lobes in inspiration and expiration for eac
group. Idiopathic pulmonary fibrosis patients and controls exhibite
significant attenuation changes in inspiration and expiration with th
highest attenuation differences seen in the lower lobes for both group
(P < 0.005), in accordance with the predominant affected area of UI
whereas the comparison of upper and lower lobes attenuation chang
yielded no significant difference in COPD patients (P = 0.241) (Fig. 5
Attenuation Values of Air Ventral to the Patient
As an internal control, the air ventral to the patient was measure
at the level of the carina both at inspiration and expiration for the IP
patients. Mean HU values of these measurements were −1001 (SDFIGURE 1. Attenuation in an unaffected-appearing lung area in the lower
lobe of an idiopathic pulmonary fibrosis patient. During inspiration,
attenuation was −874 HU; during expiration, HU −612 HU.
© 2017 Wolters Kluwer Health, Inc. All rights reserved.
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                              This paper can be cited using the date of access and the2.11) HU in inspiration and −999.7 (SD, 2.36) HU in expiration. Th
highest difference for a pair of inspiration/expiration measuremen
was 3 HU.
Interobserver Variability
Interobserver variability, tested with single score intraclass corr
lation, yielded an ICC of 0.968. An ICC of greater than 0.90 indicat
excellent reliability.15
ROC Analysis
For the assessment of the 3-class discriminative power of C
density changes, we generated 3-dimensional ROC surfaces and compute
the respective VUS as the equivalent of the 2-dimensional ROC ar
under the curve (AUC) (Fig. 6A). The exemplary VUS for the diffe
ence in attenuation changes (for Reader 2) is 0.7265 (95% confiden
interval, 0.4068–0.8876, a random predictor would yield 0.1667).
Classical ROC analyses were calculated for percent attenuatio
changes between inspiration and expiration in IPF and controls. Whe
considering the whole lung, the AUC was 0.811 for reader 1 an
0.814 for reader 2 (Fig. 6B). For the lower lobes alone, the AUC w
0.830 for reader 1 and 0.872 for reader 2 (Fig. 6C). Based on the me
surements of reader 2, an attenuation change in HU of approximateFIGURE 2. Absolute Hounsfield units (HU) values for inspiration and
expiration between controls and patients with idiopathic pulmonary
fibrosis (for all lobes). There was no significant difference in the inspiration
HU values between these 2 groups (light-colored boxes; P = 0.174).
However, for expiration, the HU differences were statistically significant
(dark-colored boxes; P < 0.001). *P < 0.001; n.s. not significant.
www.investigativeradiology.com 3
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TABLE 3. Average Density Differences in Percent in the Upper Lobes,
Middle Lobe/Lingula, and Lower Lobes With Standard Deviation for
the Different Groups
Controls, % COPD, % IPF, %
Upper lobe R1 9.3 ± 4.3 7.5 ± 4.9 23.2 ± 10.1
R2 9.2 ± 4.2 6.7 ± 3.7 21.6 ± 14.3
Middle lobe/lingula R1 8.9 ± 5.5 7.7 ± 4.6 20.9 ± 12.1
R2 8.3 ± 4.1 5.6 ± 3.8 19.5 ± 9.3
Lower lobe R1 18.0 ± 10.6 9.2 ± 5.6 43.2 ± 23.6
R2 19.7 ± 11.1 7.9 ± 4.8 54.1 ± 29.9
COPD indicates chronic obstructive pulmonary disease; R1, reader 1; R2,
reader 2.
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              27% between inspiration and expiration in the lower lobe could be use
as a discriminator between IPF and controls with a sensitivity of 80
and a specificity of 83%.
When based on the absolute HU values in expiration, therewas a
AUC of 0.778 for reader 1 and 0.846 for reader 2. Here, a discriminatFIGURE 3. Representative computed tomography density measurements
control subject, (C and D) COPD patient, and (E and F) idiopathic pulmon
4 www.investigativeradiology.com
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                              This paper can be cited using the date of access and theat a HU of −658 could be established for the expiratory scans with
sensitivity of 73% and a specificity of 73%.
DISCUSSION
Computed tomography attenuation in the lungs of IPF patien
seems high in expiratory scans. We thus decided to further analyze th
phenomenon and investigated absolute CT lung density and densi
changes during inspiration and expiration in areas with no or minim
abnormalities in IPF patients in comparison to those of COPD patien
and patients with no radiological signs of ILD. We found that lungs
IPF patients exhibited significantly higher attenuation values in expir
tion than those of controls, whereas there was no significant differen
in HU between the lungs of IPF patients and controls during inspiratio
Attenuation changes between inspiration and expiration were signif
cantly different among all the 3 groups. To our knowledge, this is th
first study systematically analyzing lung density of IPF patients durin
inspiratory and expiratory CT scans.
Expiratory chest CT scans have been proven to be useful for th
evaluation of certain diffuse lung diseases such as emphysema or ILD.
They provide functional and dynamic information on lung parenchym
small airways, and interstitium that would otherwise (ie, only by meaof lower lung lobes in inspiration (left) and expiration (right) in (A and B) a
ary fibrosis patient. White circle depicts region of interest.
© 2017 Wolters Kluwer Health, Inc. All rights reserved.
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FIGURE 4. One-factor ANOVA analysis yielded significant difference in
attenuation changes between inspiration and expiration of unaffected
lung parenchyma among all the subject groups in all lung lobes
(P < 0.001) (A: upper lobes; B: middle lobe/lingula; C: lower lobes). For
idiopathic pulmonary fibrosis patients, highest differences in densities
were observed in the lower lobes (C),which is the predominant affected
site of UIP. *P < 0.001.
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              of an inspiratory CT scans) be unavailable. In patients with COP
and emphysema, expiratory scans help to identify lung areas with fixe
hyperinflation versus areas that still take part in the volume change of
respiratory cycle and thus facilitate planning of local therapy.19,20
Earlier densitometry studies focusing on COPD patients r
ported mean lung density ranging from −880 to −813 HU in inspiratio
and from −840 to −736HU in expiration.21–23 The density wemeasure© 2017 Wolters Kluwer Health, Inc. All rights reserved.
                              Copyright © 2017 Wolters Kluwer Health, Inc. Unauthori
                              This paper can be cited using the date of access and thein the lungs of COPD patients ranged from −901 to −881 HU in insp
ration and from −854 to −820 HU in expiration. These values are
the lower range or below those of earlier studies. A possible explanatio
for this difference—besides a different set of patients—might be foun
in a different measurement technique; although the aforementioned a
thors measured the whole lung, we measured small ROIs with a min
mal amount of included blood vessels that might have lowered th
attenuation values.
For controls, we found attenuation values between −882 H
in inspiration and −721 HU in expiration, which is in the range
earlier publications.22
Many studies have correlated lung function tests and quantitativ
parameters such as lung volume or mean density in inspiratory and exp
ratory CT scans.24 It has been shown that air trapping of emphysema an
hyperinflated areas correlates with functional loss of lung parenchym
Expiratory scans are part of the established workup in lung di
eases with bronchiolitis such as hypersensitivity pneumonitis or co
strictive bronchiolitis after lung transplantation.25 Interpretation
mosaic pattern present on inspiratory CT scans is further refined by e
piratory CT scans. Lobulated areas of lower attenuation, which repr
sent retained gas in the secondary pulmonary lobules, are translate
as an obstruction of the expiratory airflow, seen inmany obstructive di
eases, such as asthma, emphysema, bronchiolitis, and many others.17,
Although expiratory CT scans are routinely performed for th
aforementioned lung diseases, no such approach exists for patients wi
IPF. It is still debated when an expiratory CT scan should be acquired
terms of additional information gained as well as radiation concern
varying between volumetric and noncontiguous CT scans. Some radio
ogists perform expiratory CTs for ILD patients with the sole purpose
exclude air-trapping and thus to be able to exclude a pattern that is i
compatible with the diagnosis of UIP. In a survey among members
the European Society of Thoracic Imaging, only 58% of responden
stated to routinely perform expiratory scans in patients with ILD.
The common paradigm indicates that expiratory scans do not provid
further information than to exclude air-trapping. Possibly due to this u
tested assumption, there is a lack of systematic studies having analyze
expiration in IPF and other ILD patients.
Our finding of increased density during expiration in radiolog
cally healthy-appearing tissue of IPF lungs fits to the concept of alve
lar collapse and collapse induration of IPF pathogenesis.4 Idiopath
pulmonary fibrosis patients are known to have defective surfactant pr
duction,5 and mutations of surfactant protein have been detected
some patients.27 Surfactant dysfunction has been associated with fibr
sis and could contribute to increased collapsibility followed by collap
induration as a precursor of fibrosis.4
As histopathological staining for fibrogenic pathways was altere
in apparently healthy lung tissue, the fibrotic process affects the enti
lung of IPF patients.28 In analogy, we observe increased density
healthy-appearing tissue, which might indicate increased collapsibilit
Recently, Mai et al29 reported that even in areas with no or mi
imal abnormalities on CT images, there were islands of increased atte
uation located in or near the interlobular septa on micro-CT scan
These areas corresponded to fibroblastic foci (ie, active, very recent
formed fibrotic areas) at histologic analysis. The authors further foun
an abnormal adjacency of alveolar walls suggesting alveolar collaps
Because we also focused on normal-appearing lung areas, it seems po
sible that the increased density we perceived on expiratory scans mig
be attributable to alveolar collapse. Thus, areas of increased attenuatio
in expiration that seem to be normal on inspiratory CTmight already b
affected by fibrotic changes. Previous studies have shown that patien
with histologically proven IPF can present without the typical CT fin
ings of UIP.30
With the availability of new antifibrotic drugs such as pirfenidon
and nintendanib31,32 that slow down disease progression, treatme
response needs to be measured. However, the most commonly usewww.investigativeradiology.com 5
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FIGURE 5. Differences in density between upper lobe and lower lobe for controls, COPD, and idiopathic pulmonary fibrosis. T test revealed
significant differences between upper lobe versus lower lobe for idiopathic pulmonary fibrosis patients and controls but not for COPD patients.
*P < 0.001; ns, not significant.
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              outcome measurement based on FVC is difficult to assess and ne
methods to evaluate treatment response are urgently required. O
findings that apparently unaffected lung parenchyma in IPF lung
has altered density in inspiration and expiration might be an earli
outcome marker to evaluate drug effects before radiological fibros
or lung functional FVC changes become apparent, if treatments affeFIGURE 6. A, Three-dimensional ROC curves surfaces for the assessment o
surface as the equivalent of the 2-dimensional ROC area under the curve (AU
relative difference in lung attenuation between inspiration and expiration is 0
yield 0.1667). B, ROC curve for attenuation changes between inspiration a
controls. For the whole lung, the AUCwas 0.811 for reader 1 (R1) and 0.81
and expiration for IPF in comparison to controls. For the lower lobes alone, the A
measurements of reader 2, an attenuation change inHUof approximately 27%b
between IPF and controls with a sensitivity of 80% and a specificity of 83%.
6 www.investigativeradiology.com
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quired to validate our findings.
This study has several limitations. There was no objective co
trol of the degree of inspiration and expiration. Although all patien
were instructed in the same way and CT scans were performed in ma
imal end-inspiration and end-expiration, there is a possibility thf the 3-class discriminative power. The respective volume under the ROC
C) was computed. The exemplary volume under the ROC surface for the
.7265 (95% confidence interval, 0.4068–0.8876; a random predictor would
nd expiration for idiopathic pulmonary fibrosis (IPF) in comparison to
4 for reader 2 (R2). C, ROC curve for attenuation changes between inspiration
UC was 0.830 for reader 1 (R1) and 0.872 for reader 2 (R2). Based on the
etween inspiration and expiration in the lower lobe could be used as a discriminator
Figure 6 can be viewed online in color at www. investigativeradiology.com.
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              interindividual variations might have occurred. Lung density varies a
cording to the degree of inspiration and expiration. For future studie
the use of portable spirometers could be applied to control for the
subjective variations.
The CT protocol used in this study consisting of an inspirato
scan at standard dose and an expiratory scan at low dose might hav
had an impact on the density units. It is known, however, that chang
in tube current (milliampere) alter the amount of noise but do not affe
the HU. In an additional measurement, we evaluated the air ventral
the patient at the level of the carina both at inspiration and expiratio
to control for any systematic error. The mean HU values showed virt
ally the same HU (−1001 [SD, 2.11] HU in inspiration and −999.7 (SD
2.36) HU in expiration). Because the difference in attenuation betwee
inspiration and expiration in the lung parenchyma was in the order
50 to 350 HU, this extremely small difference is very unlikely to hav
had an influence on the results. For consistency, all patients, that is, al
the control and COPD groups, were examined in the same way.
Finally, the small number of patients is a limitation for the stati
tical power of this study. However, a power analysis conducted befo
this study revealed that the contrasts in CT density between IPF patien
and the other 2 groups were so large that a statistically significant resu
was achieved.
In conclusion, expiratory lung density is increased in IPF
normal-appearing tissue as opposed to COPD and controls. The com
mon paradigm indicates that expiratory scans do not provide further i
formation than to exclude air-trapping. Possibly due to this unteste
assumption, there is a lack of systematic studies having analyzed exp
ration in ILD patients.We suggest that the increased density observed
expiratory scans in IPF patients might indicate early changes in the d
velopment of this disease.r-
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